Sogrya subcutaneous injection 5mg, manufactured by Novo Nordisk Pharma, contains Somatropin (genetically recombined) and is a once-weekly human growth hormone analog for treating growth hormone deficiency in pediatric patients aged 2.5 years and older, and adults. It is supplied as 5 mg/1.5 mL/kit, with YJ code 2412403G1020.
Sogrya subcutaneous injection 5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →